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Complementary DNA coding for human crl-antitrypsin has been placed under the control of the ~PR 
promotor carrier by the expression vector pCQV2 [l]. In conditions which allow transcription from this 
promotor (thermoinactivation of the repressor), Escherichia coli cells harbouring the recombinant plasmid 
pULB1114 express human al-antitrypsin (+ 9000 molecules/cell). The product has a M, of 44000, 
corresponding to mature unglycosylated cul-antitrypsin. 
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1. INTRODUCTION 
aI-Antitrypsin, one of the major components of 
plasma proteins, is synthesized in the liver and 
secreted into the plasma [2]. The enzyme functions 
mainly as an inhibitor of elastase, a protein involv- 
ed in the degradation of lung tissues [3]. 
Hereditary deficiencies of cyl-antitrypsin are 
relatively frequent [4]; when associated with en- 
vironmental factors, they result in cumulative 
pulmonary damage known as emphysema [5]. It 
has been reported [6] that human emphysematic 
conditions can be relieved by intravenous injection 
of partially purified al-antitrypsin. It thus appears 
worthwhile to try to produce sufficient quantities 
of human cul-antitrypsin through recombinant 
DNA technology to assess its curative value in 
animal models and possibly in human therapy. In 
this context, we reported [7] the cloning of full 
length cDNA coding for human cul-antitrypsin and 
its expression in bacteria as part of a fusion with 
fl-lactamase. 
We here describe the construction of a recombi- 
nant plasmid, pULB1114, where the DNA se- 
quence coding for al-antitrypsin is placed under 
the control of a strong promotor and we show that 
bacteria harbouring this plasmid express a 44-kDa 
Immunoassay for cY1-antitrypsin 
protein corresponding to mature unglycosylated 
L~I-antitrypsin. 
2. MATERIALS AND METHODS 
Restriction endonucleases, T4 DNA polymerase 
and T4 DNA ligase were purchased from 
Boehringer-Mannheim and used as recommended 
by the manufacturers. E. coli K-12 strain 294 
(endA, thr-, hsr-, hsm~+) was used for bacterial 
transformations [7]. Plasmids used in this work, 
pCQV2 and pULB1523, have been described in 
[1,71. 
LB medium for E. coli growth was as in [8] with 
the addition of 50pg/ml ampicillin for the selec- 
tion of plasmid transformants. DNA fragments 
were purified from polyacrylamide gels by elec- 
troelution followed by two phenol extractions. 
Colony hybridization experiment follows the pro- 
cedure in [9]. 
Cell extracts for immunodetection of 
cul-antitrypsin were prepared as follows: a 20-ml 
culture in LB medium of the clone to be analyzed 
was incubated at 30°C up to an &O of 0.15; half 
the culture was then quickly heated to 42’C by the 
addition of 1 vol. hot medium (SO’C) and further 
incubated for 2 h at 42°C. The remaining half of 
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the culture was treated similarly at 30°C. Cells 
were collected by centrifugation, resuspended in 
1 ml of lysis buffer (50 mM Tris-Cl, pH 7.5; 
60 mM EDTA, 25% sucrose, 500 pg/ml lysozyme) 
incubated for 30 min at 4°C then treated for 
15 min at 4°C with 0.01% Triton X-100. The 
resulting extracts were centrifuged for 20 min at 
10000 rev./min and frozen at -20°C. 
Immunodetection of ai-antitrypsin in cell ex- 
tracts was done using the ELISA system described 
in [7]. 
Characterization of the ai-antitrypsin synthesiz- 
ed in bacteria was done by SDS-PAGE [lo] 
followed by western blotting on nitrocellulose 
sheets [l 11. Blots were saturated with phosphate 
saline buffer (PBS) pH 7.5, containing 0.1% 
Tween 80, 10% horse serum and 1% bovine serum 
albumin (4 h at room temperature). Sheets were 
then washed 3 times with PBS buffer containing 
0.1% Tween 80 and incubated overnight at 20°C in 
saturation buffer supplemented with mouse an- 
tihuman ai-antitrypsin serum (dilution l/1000). 
After 5 washes with PBS/Tween buffer, the blots 
were incubated in the same buffer supplemented 
with peroxidase-labelled goat antimouse serum 
(GAM-POD, lOpg/ml). Following 5 washes with 
PBWTween buffer, the nitrocellulose sheets were 
exposed to the chromogenic substrate (25 min in 
100 mM Tris-Cl, pH 7.6; 10 mg diaminoben- 
zidine, 100 ~1 of a 10% urea peroxide solution) and 
finally rinsed with distilled water. 
3. RESULTS 
3.1. Construction of the recombinant plasmid 
pULB1114 
The plasmid vector pCQV2 [l] contains a strong 
promoter APR, the CTO ribosomal binding site and 
the thermosensitive repressor for the PR promotor; 
in addition a convenient BamHl site allows inser- 
tion of foreign genes downstream of an ATG 
codon. To construct the recombinant plasmid 
pULB1114, we first linearized the pCQV2 DNA 
with the enzyme SafI, treated the DNA with T4 
DNA polymerase to obtain blunt ends and then cut 
with the enzyme BamHl to generate a plasmid 
molecule suitable to accept any foreign DNA frag- 
ment having a 5’ BamHl cohesive end and a 
3’-blunt end (fig.la). 
Plasmid pULB1523 carries the full length cDNA 
68 
Fig. 1. Construction scheme of the recombinant plasmid 
pULB1114. A 1322 bp DNA fragment coding for 
mature cq-antitrypsin [7] was ligated to the BamHl site 
adjacent to an ATG codon in plasmid pCQV2 [l]. 
Hybrid molecules were used to transform competent E. 
coli cells and transformants were selected on ampicillin- 
containing medium. 
coding for human ai-antitrypsin [7]; we excised 
from this plasmid the HhaI fragment encompass- 
ing the ai-antitrypsin sequence, made it blunt end 
with T4 DNA polymerase, then cut it with the en- 
zyme BamHl. This procedure generates a DNA 
fragment having a 5’ BamHl cohesive end, 
located at position 76 in the ai-antitrypsin DNA 
sequence (second amino acid of the mature pro- 
tein) and a 3 ‘-blunt end downstream to the stop 
codon (fig. 1 b). The treated pCQV2 DNA was then 
ligated to the cyi-antitrypsin DNA fragment and 
the resulting hybrids were used to transform com- 
petent E. coli MM294 cells. Transformants were 
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selected at 30°C for ampicillin resistance and 
strains carrying the appropriate insert were iden- 
tified by colony hybridization [9] using a nick- 
translated human aul-antitrypsin cDNA probe [7]. 
Clones positive in this assay (not shown) were 
analyzed by restriction digestions to verify the 
presence of a typical 1301 bp fragment 
(BamH 1 -MI) encompassing the sequence starting 
at nucleotide 76 (second amino acid of mature 
a,-antitrypsin) and ending 120 bp downstream to 
the stop codon (fig.l,2). One clone satisfying to 
this condition, pULBl114, was chosen for expres- 
sion analysis. 
3.2. Expression of human cul-antitrypsin in clone 
pULBlI14 
Cells carrying either the control plasmid pCQV2 
or the pULBll14 plasmid were grown at 30°C then 
quickly heated at 42°C in order to inactivate the h 
repressor and allow induction (see section 2). 
Pelleted bacteria were lysed with lysozyme and 
Triton X-100 and the resulting extracts were 
analyzed in an amplified immunosorbant assay 
1234567 
-1301 bp. 
Fig.2. Restriction analysis of the plasmid pULBlll4. 
Plasmid DNA was digested with the enzymes BamHl 
and PstI and analyzed on 1% agarose gel. MI standards 
are fragments of X DNA cleaved with EcoRI and 
HindIII. The arrow points to the expected 1301 bp 
fragment derived from the digestion of pULBll14 with 
BamHl and Pd. (1) M, standards h EcoRI HindIII; 
(2,4,6) pULBll14 DNA undigested; (3,5,7) pULBlll4 
Fig.3. Western blot of bacterially synthesized 
cY1-antitrypsin. Protein extracts were prepared for 
electrophoresis on 15% polyacrylamide gels as described 
in section 2. Nitrocellulose blots were reacted with 
mouse antihuman cul-antitrypsin serum followed by 
peroxidase-labelled goat antimouse serum and the 
chromogenic substrate (section 2). Source of protein 
samples: (1) pCQV2, control plasmid at 3O’C; (2) 
pCQV2, at 42°C; (3) pULBll14 at 30°C; (4) pULBIll4 
at 42°C. M, standards (bovine serum albumin, 
ovalbumin, chymotrypsinogen, lysozyme) and native 
human cul-antitrypsin were run on the same gel, 
DNA digested with BumHl and PM. electroblotted and stained with Coomassie blue. 
Table 1 
Expression of human cY1-antitrypsin in bacterial extracts 
Clone Growth at 
(“C) 
cY1-Antitrypsin 
(ng/ml extract) 
pCQV2 
pULBll14 
30 
42 
30 
42 
<3 
<3 
<3 
3400 
(8854 molecules/cell) 
Procedures to prepare cell extracts and to dose 
cul-antitrypsin are described in section 2 
described in [7]. This assay which allows the detec- 
tion of low levels of aI-antitrypsin (down to 
1 ng/ml) was calibrated using a standard human 
cY1-antitrypsin preparation then performed on cell 
extracts derived from cultures at 30°C and 42°C. 
As seen in table 1, expression of human 
cul-antitrypsin could be detected only in the clone 
pULBll14 when thermoinduction conditions were 
used (8854 molecules of al-antitrypsin/cell). The 
expressed product was characterized by 
SDS-PAGE, western blotting and immunodetec- 
tion on the nitrocellulose blots. Fig.3 shows that a
MW 
(mature human x,-AT) 
66 5: 43 25 
(Kdaltons) 
I II I >,> 
;; 
I 
44 Kd 
69 
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single product is expressed at 42°C in clone 
pULBll14. This polypeptide has a molecular mass 
of 44000, consistent with the known molecular 
mass of mature unglycosylated human antitrypsin 
[Ql. 
4. DISCUSSION 
The cDNA sequence coding for mature human 
cYr-antitrypsin has been fused to the ATG codon 
carried by the plasmid pCQV2 [l]. In thermoin- 
duction conditions, E. coli cells carrying the 
recombinant plasmid express a polypeptide 
specifically recognized by anti human 
cur-antitrypsin serum. The molecular mass of the 
bacterially-produced cur-antitrypsin is consistent 
with the known A4, (44256) of human mature 
unglycosylated ar-antitrypsin [ 121. The level of ex- 
pression, nevertheless, remains relatively low when 
compared to levels obtained using vector pCQV2 
to produce other proteins [l]. This could result 
from internal foldings of the mRNA, to fortuitous 
termination sites in the DNA or to mRNA and/or 
protein instability. Solving these problems is ob- 
viously a prerequisite to obtain higher expression 
levels. 
Attempts to demonstrate biological activity of 
the bacterially-synthesized cyr-antitrypsin have 
been unsuccessful so far. This failure could be due 
either to inactivation of the molecule in the ex- 
tracts or to a lack of sensitivity of the assay we us- 
ed (inhibition of trypsin activity). To solve this 
problem, it might be necessary to use protease- 
deficient bacteria and/or to purify at least partially 
the cYr-antitrypsin produced in E. coli. 
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